NKGN: NKGen Biotech Expected Profit

Corporate company logo of NKGen Biotech Corp (NKGN)

The growth potential of NKGen Biotech, Inc. (NKGN) relies on insurance reimbursements for the treatment of brain degeneration. The company's target profit reflects the market consensus among investors, where records a new level mark. The advantage of the SNK01 platform provides pricing power by combating neuroinflammation. Meanwhile, the development of cell therapy is protected by a humanitarian consensus, which eliminates the impact of geopolitical risks.

NKGN: NKGen Biotech Corp Projected Net Profit 07/04/2022 - 11/17/2026

Analytical breakdowns for NKGen Biotech, Inc. (NKGN)

- price and consensus price forecast:
- market capitalization information:
Fundamental company valuation:NKGen Biotech, NKGN
Core merchandise of NKGen Biotech Corp

NKGen Biotech, Inc. (NKGN) is developing innovative cell therapy methods to combat Alzheimer's disease. This prospective profit chart reflects market expectations for future cash flows based on institutional demand conditions. The metric measures the fundamental maturity of the business model through projected performance. Analysis of the prospective profit chart allows for the identification of the risk of overpaying for the asset. The current share price depends directly on the probability of a scientific breakthrough by management.

Key competitors

BIIB (Biogen) - Projected Future Earnings|Net Profit Forecast NBIX (Neurocrine Biosciences, Inc.)|Projected Future Earnings RGC|Axsome Corp - Net Profit Forecast|Projected Future Earnings ACAD (ACADIA Corp)|XENE: Net Profit Forecast|Viking Therapeutics Inc - Projected Future Earnings|Expected Net Profit Supernus Pharmaceuticals, Inc.|Catalyst Pharmaceuticals Inc (CPRX) - Expected Profit|DNLI (Denali Therapeutics Inc) - Expected Profit|Expected Profit Harmony Biosciences Holdings, Inc.|Expected Profit BHVN|Future Profit AMLX (Amylyx Pharmaceuticals, Inc.)|Future Net Profit TRVI|Expected Profit Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Expected Profit|CBLL: Future Profit|Expected Net Income PRTA (prothena.com)|Alector, Inc. (ALEC) - Expected Profit|Net Profit Forecast ANNX|Expected Profit Omeros Corp.|Neurogene Therapeutics (NGNE) - Company Profit Forecast|Projected Future Earnings ACIU|VYGR (Voyager Therapeutics) - Expected Net Income|Projected Future Earnings NMRA (neumoratx.com)|SCLX: Net Profit Forecast|TVGN - Expected Profit|Expected Net Profit Alpha Cognition Inc.|CGTX: Projected Future Earnings|inhibikase.com (IKT) - Projected Future Earnings|Expected Profit Cassava Sciences Inc|ASRT - Projected Net Profit|Expected Profit Coya (COYA)|Projected Future Earnings VistaGen Therapeutics Inc (VTGN)|Ovid Therapeutics Inc. - Future Profit|Company Profit Forecast Acumen Pharmaceuticals (ABOS)|CervoMed Corporation - Projected Future Earnings|Company Profit Forecast alteritytherapeutics.com ATHE|CLNN: Projected Future Earnings|Expected Net Profit PepGen Corp (PEPG)|Expected Profit Jupiter Neurosciences, Inc.|RLMD: Expected Net Income|Projected Future Earnings ANVS|Future Profit Grace Tx GRCE|Expected Profit Firefly Neuroscience, Inc AIFF|KLTO: Net Profit Forecast|NRSN - Expected Profit|RVPH: Expected Profit|MTVA (MetaVia Inc.) - Future Profit|NeurAxis Inc. (NRXS) - Projected Future Earnings|Expected Profit Helius Medical|Passage Bio, Inc. - Forward Earnings|Future Profit NEUP (Neuphoria)|NERV - Expected Net Profit|Projected Future Earnings ATHA (athira.com)|Projected Future Earnings Addex Therapeutics Ltd ADXN|Alzamend Neuro, Inc. - Projected Future Earnings|CYCN - Projected Future Earnings|PTIX (Protagenic Therapeutics, Inc.) - Future Profit|Expected Net Profit Pasithea (KTTA)|Expected Profit Cortigent|Expected Net Profit Avenue Therapeutics Inc. ATXI|Expected Profit brainstorm-cell.com (BCLI)|Future Profit Cara Therapeutics, Inc CARA|Projected Future Earnings CHRO (chromocell.com)|Expected Net Income ELYM|Intra-Cellular Therapies Inc. - Projected Future Earnings|Expected Net Profit Longboard Pharmaceuticals Inc|Marinus (MRNS) - Expected Profit|NeuroBo Pharma (NRBO) - Projected Future Earnings|Future Profit SAGE|Net Profit Forecast SNPX (Synaptogenix, Inc.)|Expected Profit Trevena, Inc (TRVN)|VIGL (Vigil Neuroscience Inc.) - Expected Net Income|Expected Profit Anew Medical WENA|Future Net Profit CERE (Cerevel)